Picture of NuVasive logo

NUVA — NuVasive News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid Cap

NuVasive Inc expected to post earnings of 35  cents a share - Earnings Preview

* NuVasive Inc  NUVA.OQ   NUVA.O  is expected to show a rise in
quarterly revenue when it reports results on May 5.
* The San Diego, California-based company is expected to report
 a 0.7% increase in revenue to $261.769 million from $259.88
million a year ago, according to the mean estimate from 16
analysts, based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for NuVasive Inc is for
earnings of 35 cents per share. For the same quarter last year,
the company reported earnings of 48 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 8 "strong buy" or "buy," 8
"hold" and 3 "sell" or "strong sell." 
* The mean earnings estimate of analysts had fallen by
about 1.0% in the last three months.​
* Wall Street's median 12-month price target for NuVasive Inc is
$69.5​, about 3.1% below​ its last closing price of $71.66. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  0.55        0.55       0.59      Beat    6.4
 Sep. 30 2020  0.23        0.24       0.55      Beat    130.9
 Jun. 30 2020  -0.40       -0.47      -0.40     Beat    15.6​
 Mar. 31 2020  0.38        0.41       0.48      Beat    17.3
 Dec.          0.64​       0.64       0.73      Beat    14.3​
 31​ 2019​                                              
 Sep. 30 2019  0.54        0.53       0.59      Beat    10.5​
 Jun. 30 2019  0.56        0.56       0.63      Beat    13.1
 Mar. 31 2019  0.42        0.41       0.53      Beat    29.1
 This summary was machine generated May 3 at 21:29 GMT.  All
figures in US dollars unless otherwise stated

Recent news on NuVasive

See all news